CA2254052A1 - Methods and systems for deployment of a detachable balloon at a target site in vivo - Google Patents
Methods and systems for deployment of a detachable balloon at a target site in vivo Download PDFInfo
- Publication number
- CA2254052A1 CA2254052A1 CA002254052A CA2254052A CA2254052A1 CA 2254052 A1 CA2254052 A1 CA 2254052A1 CA 002254052 A CA002254052 A CA 002254052A CA 2254052 A CA2254052 A CA 2254052A CA 2254052 A1 CA2254052 A1 CA 2254052A1
- Authority
- CA
- Canada
- Prior art keywords
- holder
- sheath
- disposed
- balloon
- target site
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/12136—Balloons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12099—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/0004—Closure means for urethra or rectum, i.e. anti-incontinence devices or support slings against pelvic prolapse
- A61F2/0031—Closure means for urethra or rectum, i.e. anti-incontinence devices or support slings against pelvic prolapse for constricting the lumen; Support slings for the urethra
- A61F2/0036—Closure means for urethra or rectum, i.e. anti-incontinence devices or support slings against pelvic prolapse for constricting the lumen; Support slings for the urethra implantable
- A61F2/004—Closure means for urethra or rectum, i.e. anti-incontinence devices or support slings against pelvic prolapse for constricting the lumen; Support slings for the urethra implantable inflatable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M2025/1043—Balloon catheters with special features or adapted for special applications
- A61M2025/1054—Balloon catheters with special features or adapted for special applications having detachable or disposable balloons
Abstract
Methods and systems for deployment of a detachable, inflatable balloon at a target site in vivo are disclosed. In one aspect of the invention, the method involves providing a holder; passing a protective sheath through the lumen of the holder; passing a positioning element through the lumen of the sheath; advancing the positioning element to the target site in vivo; withdrawing the positioning element while keeping the sheath fixed relative to the holder; passing a detachable, inflatable balloon coupled to a distal end of a delivery device through the sheath; withdrawing the sheath into a retractor disposed at proximal end of the delivery device such that the delivery device remains fixed relative to the holder and the balloon is exposed to the target site in vivo; and inflating and detaching the balloon. In another aspect, the system includes a holder; a protective sheath configured for insertion through the holder; a delivery device for carrying a detachable, inflatable balloon disposed at its distal end, the delivery device configured for insertion through the sheath; and a retractor, disposed at a proximal end of the catheter, for withdrawing the sheath whereby the delivery device remains fixed relative to the holder and the balloon is exposed to the target site.
Description
CA 022~40~2 1998-11-10 METHODS AND SYSTEMS FOR DEPLOYMENT OF
A DETACHABLE BALLOON AT A TARGET SITE IN VIVO
Back~round of the Invention The field of this invention concerns the delivery of inflatable, detachable balloons in medical procedures involving blood vessels, body cavities, and the like, and, in particular, in medical procedures involving the treatment of urinary incontin~ e.
Various techniques have been used for the delivery of detachable balloons. See, for example, Haber et al., U.s. Patent No. 4,832,680, issued May 23, 1989; U.S. Pat.
No. 4,802,479, issued Feb. 7, 1989; U.S. Pat. No. 4,773,393, issued Feb. 27, 1988, and U.S. Patent No. 4,686,962, issued Aug. 18, 1987. Haber et al., in particular, describe an extensible inflatable containment membrane which is implanted between the urethra and the subcutaneous corpus spongiousum of a patient to overcome urinary incontinence.
The containment membrane of Haber et al. is positioned using a hypodermic needle.
Such devices and methods require complicated devices for stabilizing the delivery of the balloon during the insertion and positioning. Such devices and methods also may require specialized instrumentation to accommodate balloon insertion and positioning with a hypodermic needle.
There exists a need for better methods and systems for accurate delivery of inflatable, detachable balloons. A simple system for stabilizing balloon delivery devices would satisfy a long felt need in the art by reducing the overall procedure time, ma~cimi7ing the efficacy of the methods and systems and, hence, reducing patientdiscomfort.
Summary of the Invention Methods and devices are disclosed for the deployment of detachable, inflatable balloons at a target site in a patient in vivo. The present invention is based on the recognition that a balloon delivery device can be inserted through a protective sheath which is slidably mounted within a holder. The sheath can be retracted and, if desired, locked, such that the delivery device remains fixed relative to the holder and the balloon is exposed to the target site in vivo.
In one aspect of the invention, a detachable, inflatable balloon is deployed to a target site in vivo according to the following steps. A holder having an inner lumen, a proximal receiving end and a distal exiting end is provided and a protective sheath passed through the holder inner lumen at the proximal receiving end until a distal end of the sheath extends to at least the distal exiting end of the holder. A positioning element is passed through an inner lumen of the sheath until a positioning element tip disposed at CA 022~40~2 1998-11-10 a distal end of the positioning element extends beyond the holder's distal exiting end and the distal end of the sheath. The positioning element tip is advanced to the target site in vivo and used to establish a pocket. The positioning element is then withdrawn from the sheath such that the sheath remains fixed relative to the holder. A ~let~h~ble inflatable balloon coupled to a distal end of a delivery device is passed through the sheath. The sheath is withdrawn into a retractor disposed at a proximal end of the delivery device such that the delivery device remains fixed relative to the holder and the balloon is exposed to the target site in vivo. The balloon is then infl~te~l, preferably with an inert biocompatible material (e.g. a polymerizable solution), and detached at the target site in vivo.
In one embodiment of the invention, the step of withdrawing the sheath into the delivery device retractor can include rotating the delivery device retractor such that a hub disposed at a proximal end of the sheath is withdrawn into the delivery device retractor. In another embodiment, the step of passing the balloon through the sheath can include passing the delivery device retractor over a hub disposed at the proximal end of the sheath until the delivery device retractor contacts a stopper means, disposed on the holder, for preventing passage of the delivery device through the holder beyond a pre-determined point.
In other embodiments, the step of providing the holder can include providing a stabilizing means, such as a flange, disposed at a distal exiting end of the holder, for stabilizing the holder against a surface exterior to the holder. The step of providing the holder can also include providing an outer holder member and an inner holder member, each having an inner lumen, a proximal receiving end and a distal exiting end; and inserting the inner holder member at least partially into the outer holder member to form the holder; and the step of advancing the positioning element tip to the target site in vivo can also include progressively releasing a projection element disposed on the inner holder member into corresponding projection releasing elements disposed on the outer holder member to provide a visual indication of the depth of insertion. The step of progressively releasing a projection element can include depressing a lever arm having a projection tab disposed on the inrer holder member below a surface of the outer holder member projection releasing element.c. This step can also include indexing the projection tab from one releasing element to another.
In still other embodiments, the step of passing the sheath through the holder can include passing a guide, disposed on the sheath, along a corresponding passageway, disposed on the holder, such that passage of the sheath through the holder is directed along a longitudinal axis relative to the holder. The step of passing the sheath through CA 022~40~2 1998-11-10 the holder can also include passing the sheath through the holder until a tab, disposed on the holder, is captured by at least one mating receptacle, disposed on the sheath, thereby inhibiting further movement of the sheath relative to the holder.
In further embo.liment~, the step of providing a holder can include providing a fitting means, disposed at a distal end of the holder, for providing an ~tt~r~lment to a viewing instrument; providing a sealing means disposed at the distal exiting end of the holder for providing a seal between the holder and a viewing instrument holder inner lumen; and/or providing a viewing instrument capable of ~ çhment to the distal exiting end of the holder, for directly vi.c~ ing the target site of a patient in vivo.
In another aspect of the invention, a system for deploying a detachable, inflatable balloon to a target site in vivo is disclosed. The system can include a holder having an inner lumen, a proximal receiving end and a distal exiting end; a protective sheath configured for insertion through the holder inner lumen at the proximal receiving end and extentling to at least the distal exiting end of the holder, including a hub disposed at a proximal end of the sheath, and a shaft portion extending outwardly from the hub along a longitudinal axis, the hub and the shaft each having an inner lumen; a delivery device for carrying a detachable, inflatable balloon at its distal end, the delivery device configured for insertion through the sheath; and a retractor disposed at a proximal end of the delivery device for withdrawing the sheath whereby the delivery device remains fixed relative to the holder and the balloon is exposed to the target site.
In other embodiment~, the delivery device retractor can include a head for withdrawing the hub of the sheath upon movement of the head. The head can be internally threaded for withdrawing the sheath hub upon rotation of the head. The holder can include a stopper means, disposed close to a proximal end of the holder, for limiting passage of the delivery device through the holder at a pre-determine-l point; a stabilizing means, such as a flange, disposed at a distal end of the holder, for stabilizing the holder against a surface exterior to the holder; a fitting means, disposed at the distal end of the holder, for providing an attachment to a viewing instrument; and/or a sealing means disposed at the distal exiting end of the holder for providing a seal between the holder and a viewing instrument. The system can further include a viewing instrument capable of ~tt~hment to the distal exiting end of the holder, for viewing the placement of the balloon.
In still other embodiments, the system can include a visual indication means, disposed on the holder, for providing a visual indication of a penekation depth of the sheath into the patient; and adjustment means disposed on the holder for adjusting the holder's length. The holder can include an outer holder member having projection CA 022~40~2 1998-11-10 WO 97t45067 PCT/US97/08979 releasing elements, an inner holder member having at least one projection element, and the inner holder member fitting at least partially into the outer holder member such that upon advancement of the inner holder member into the outer holder member, the inner holder member projection element is progressively released into the outer holdermember projection releasing elements to provide a visual indication of a penetration depth of the sheath in the patient. The inner holder member projection element can include a depressible lever arm having a projection tab, such that the arm can be depressed below a surface of the outer holder member projection releasing elements to provide for indexing of the projection tab from one releasing element to another.
In further embodiments, the system can include a guide disposed on the sheath and a passageway disposed on the holder, such that movement of the guide along the passageway during passage of the sheath through the holder directs the sheath along a longitudinal axis relative to the holder; and a tab, disposed on the holder, and at least one mating receptacle, disposed on the sheath, such that interconnection of the tab with the mating receptacle inhibits movement of the sheath relative to the holder; and/or a positioning element for passage through the sheath prior to passage of the deliver,v device through the sheath, for establishing a pocket at the target site in vivo.In still further embodiments, the positioning element can be a needle, such as ahypodermic or a cytoscopic needle or a solid wire. The lumen of the sheath can have an inside ~ met~r from about .005 mm to about 7.0 mm. The sheath can also include avisual indication means including graduation m~rking~ disposed on the distal end of the sheath, for providing a visual indication of a penetration depth of the sheath into the patient. The delivery device can include an inner catheter enclosed within an outer c~th~ter, the inner catheter having a distal end extending at least to a distal end of the outer ç~theter.
Brief Description of the D. ..~ s FIG. 1 is an exploded side view of the system including a holder, a protective sheath, and a delivery device according to the invention;
FIG. 2 is a more detailed side view of the retractor component of the delivery device of FIG. l;
FIG. 3A is an expanded side view of the holder of FIG. 1 having inner and outer holder members;
FIG. 3B is an illustration of the passage of a protective sheath through an inner and an outer holder member;
CA 022~40~2 1998-11-10 FIG. 3C shows the protective sheath fully inserted into a holder including an inner and an outer holder member;
FIG. 3D is an enlarged view of the holder illustrating a projection element including a lever arm having a depressible projection tab;
FIG. 4 is a more detailed side view of a holder illustrating a stopper mech~ni~m~tt~-'hP~ to a viewing instrument according to the invention;
FIG. SA is a view of a guide of a sheath being advanced along a passageway of a holder, FIG. SB is a view of a tab disposed along the passageway of a holder having inner and outer holder members, the tab having been captured by a mating receptacle disposed along a guide of a sheath; and FIG. 6 is a view of a positioning element of the system.
Detailed D~ ti~n The present invention pertains to methods and systems for the deployment of detachable inflatable balloons to a target site in vivo. The invention involves a delivery device which can be inserted through a protective sheath enclosed in a holder to the target site in vivo. The sheath can be withdrawn such that the delivery device remains fixed relative to the holder and the balloon is exposed to the target site in vivo.
The target site can be a site selected such that the implantation of a ~let7~h~ble balloon would be advantageous to a subject. The target site, for example, can be in close proximity to or within a duct and the purpose of the implantation of the detachable balloon is to block the duct from within or provide external pressure causing partial or complete closure of the duct. For example, the target site can be between the urethra and the subcutaneous corpus spongiousum. Alternatively, the target site can be the subureteral region of a reflux prone bladder.
The methods and systems of this invention can be used, for example, as a means for treating urinary incontin~nce. The infl~te~, detached balloon can be placed between the urethra and the subcutaneous corpus spongiousum providing a localized, controlled tissue volume increase. The corpus spongiousum would be expanded, thereby occluding the urethra.
In an additional example, the methods and systems of this invention can be used for the treatment of vesicoureteral reflux. The infl~tecl detached balloon can be placed in the subureteral region of a refluxing bladder (e.g., between the mucosal and submucosal tissue layers). The compressive effect of the infl~te~l balloon can then re-configure the ureteral tunnel so as to minimi7P the likelihood of reflux.
CA 022~40~2 1998-11-10 WO 97145067 PCTtUS97/08979 The present invention can also be used in other types of medical treatments, including, but not limited to, the tre~tment of gastroesophageal reflux, otolaryngology, reversible sterilization (i.e., in the occlusion of the fallopian tubes and/or the occlusion of the vas deferens), and urinary diverticula.
Balloon structures useful in the present invention can be formed from silicone or similar substantially non antigenic elastic materials. The lminfl~tecl balloons preferably are sized to fit into the tip of a catheter which can pass readily through the lumen of a protective sheath. The balloon structures can take various forms but preferably include a sealing mecl-~ni~m which seals the balloon upon inflation. The sealing mech~ni~m can be achieved, for example, by a constrictive collar, or a lip seal, or both.
For further description of detachable balloon structures useful in the present invention, see commonly owned U.S. PatentNos. 5,304,123 and 5,411,475, herein incorporated by reference.
The balloon can be delivered by a delivery device, such as a catheter, which is inserted through the protective sheath enclosed in a holder to the site where the balloon is to be infl~tetl In one preferred embodiment, the delivery device provides a means for not only infl~ting the balloon but also means for filling the balloon with a biocompatible material. Catheters suitable for use in the present invention are available from various sources including, for example, TFX Medical (Jaffrey, N.H.).
Various materials can be used to fill the balloon, including collagen, autologous fat or cellular extracts, an inert polymer, contrast media or saline. In one embodiment, the balloon is filled with a polymerizable solution, such as an acrylic solution which solidifies in situ. For example, the polymerizable solution can be a solution ofhydroxyethyl methylacrylate (HEMA) which is cured to a solid form by addition offerrous sulfate and hydrogen peroxide. In another embodiment, the balloon is filled with a hydrogel material such as polyvinyl pyrrolidone.
The invention will next be described in connection with certain illustrated embodiments; however, it should be clear that those skilled in the art can make various modifications, additions and subtractions without departing from the spirit or scope of the invention. For example, although the present invention is illustrated in terms of a target site close to or within a duct, the invention is applicable to other target areas in a body.
FIG. 1 is an exploded side view of system 10 including a holder 12, a protectivesheath 20, and a delivery device 30, according to the invention. The holder 12 has an inner lumen 14, a proximal receiving end 16, and a distal exiting end 18. The protective sheath 20 can be configured for insertion through the holder 12 at the proximal receiving CA 022~40~2 1998-11-10 end 16 such that it extends at least to the distal exiting end 18 of the holder 12 and can include a hub 22 disposed at the proximal end 24 of the sheath 20, and a shaft portion 26 exten/ling outwardly from the hub 22 along a longihl-lin~l axis 27, the hub 22 and the shaft portion 26 each having an inner lumen 28. The sheath 20 can also include visual indication means 78, such as graduation m~rkin~, disposed on the distal end of the shaft portion 26 of the sheath 20 for indicating the penetration depth of the sheath into the patient according to a pre-determined correlation. The delivery device 30 for carrying a detachable, inflatable balloon 32 at its distal end 34, is configured for insertion through the sheath 20 at the hub 22. A retractor 40 is disposed at a proximal end 38 of the delivery device 30 for withdrawing the sheath 20 whereby the device 30 remains fixed relative to the holder 12.
Each of the holder 12, sheath 20 and delivery device 30 can be color coded for easy assembly.
FIG. 2 is a more clet~iled side view of the retractor 40 component of the delivery device 30. The delivery device retractor 40 includes a head 42 for withdrawing the hub 22 of the sheath 20 upon movement of the head. The head 42 can be intPrn~lly threaded such that the hub 22 of the sheath 20 is withdra~vn upon rotation of the threaded head.
The head 42 can also include raised external ridges 41 to aid in gripping and/or rotating the head 42. FIG.2 also illustrates that the delivery device 30 can include an inner c~th~t~r 33 enclosed within an outer catheter 31, the distal end 34 of the inner c~tht?ter 33 e~t~n-ling at least to the distal end 35 of the outer catheter 31. Such a t~vo catheter design provides more support for safely transporting the balloon 32 to the desired target site in the patient.
FIG. 3A illustrates that the system 10 can also include a holder 55 including a visual indication means 50 for providing a visual indication of a penetration depth of the sheath 20 into the patient and an adjustment means 51 for varying the length of the holder. Such a holder 55 can include an outer holder member 52 having projectionreleasing elements 54 and an inner holder member 56 having at least one projection element 58. FIG.3B illustrates that the sheath 20 can be inserted into the lumen 62 of the inner holder member 56 and the lumen 64 of the outer holder member 52 such that the sheath 20 extends at least to the distal end 66 of the inner holder member 56 and the distal end 68 of the outer holder member 52. The inner holder member 56 enclosing the sheath 20 can fit at least partially into the outer holder member 52. As the inner holder member 56 enclosing the sheath 20 is further advanced into the outer holder member 52, the projection element 58 is progressively released into the projection releasing elements 54 providing a visual indication of a penetration depth of the sheath 20 into the patient, CA 022~40~2 1998-11-10 as shown in FIG. 3C. FIG. 3D illustrates that the projection element 58 of the inner holder member 56 can include a lever arm 70 having a projection tab 71 that can be depressed such that the projection tab 71 is indexed from one releasing element 54 to another during advancement of the inner holder member 56 into the outer holder member 52.
FIG. 4 is a more detailed side view of the holder 12 including a stopper means 72, disposed on the holder 12, for preventing further movement of the delivery device retractor 40 over the holder 12 and thus limiting passage of the delivery device 30 through the holder 12 at a pre-determined point. Stopper means 72 also provides a place for the physician to position his or her index and middle fingers, simplifying maneuvering of the system. FIG. 4 further illustrates a stabilizing means 74, such as a flange, disposed on the distal exiting end 18 of the holder 12, for stabilizing the holder 12 against a surface exterior to the holder 12. The distal exiting end 18 of the holder 12 can also include a fitting means 76 for attachment to a viewing instrument 80. The system 10 can include such a viewing instrument 80 capable of ~ hment to the distal exiting end of the holder 12. The holder 12 can further include a sealing means 82 disposed at the distal exiting end of the holder 12 for providing a seal between the holder 12 and the viewing instrument 80, thereby preventing the back-flow of fluids into the holder inner lurnen. The sealing means 82 can be made of a variety of materials, such as silicone, known to persons f~mili~r with the art.
Thus, for example, in the tre~tment of urinary incontinPn~e, the protective sheath 20 can be passed through a lumen of a viewing instrument 80 and the viewing instrument can be passed via the urethra to a target site between the urethra and the subcutaneous corpus spongiousum for injection and detachment of the balloon sul~Lllldl delivery). Alternatively, the protective sheath 20 and the viewing instrument 80 can be passed in parallel via the urethra to the target site. In addition, the protective sheath 20 can be passed through the patient's tissue parallel to the urethra to the target site for injection and detachment of the balloon 32 (pcl;u~clhldl delivery).
Positioning of the sheath can be observed via a viewing instrument passed through, for example, the urethra.
In an alternative example involving the treatment of vesicoureteral reflux, the protective sheath 20 can be passed through a lumen of a viewing instrument 80 which can be passed through the ureter to a target site (e.g., the subureteral region of a u~hlg ureter between the mucosal and submucosal tissue layers).
Various materials can be used for the sheath and/or the positioning element. Forexample, a flexible material such as nickel titanium is preferable for the sheath and/or . . .
CA 022~40~2 1998-11-10 W O 97/45067 PCTrUS97/08979 the positioning element, when these components are passed through the lumen of aviewing instrument as, for example, during transurethral delivery. When these components are passed through a patient's tissue as, for example, during periurethral delivery, an inflexible material such as stainless steel is preferable.
The viewing instrument of the present invention can be any scope capable of providing direct visualization of a target site. Examples of scopes which are inten~led to be encompassed by the present invention are endoscopes such as cystoscopes or ureteralscopes. Various cystoscopes can be used in the present invention and arecommercially available from various sources including, for example, Karl Storz Co.
(Culver, Calif.); and Olympus Corporation of (Wilmington, Mass.). Direct vi~ li7~tion is intt?n~çd to encompass visualization by the human eye or visu~li7~tion using a media which is an actual picture of what would be seen by the human eye looking through the scope, e.g. video.
FIG. SA illustrates that the system can include a guide 84 on the hub 22 of the sheath 20 which can be advanced along a corresponding passageway 86 on the holder 12, such that passage of the sheath 20 through the holder 12is directed along a longitudinal axis relative to the holder 12. Such movement of the guide 84 along the passageway 86 also prevents awkward rotation of the sheath 20 about the longitudinal axis of the holder 12..
FIG. 5A further illustrates that the system can include a tab 96 disposed on theholder 12 which can be captured by at least one mating receptacle 94 disposed on the guide 84 of the sheath 20 when the sheath 20is inserted to a pre-determined extent into the holder 12. In one embodiment, the tab 96 can include two projections disposed on opposing sides of the passageway 86. The insertion of the sheath 20 into the holder 12 including the movement of the guide 84 along the passageway 86 can expand the sides 98 of the passageway 86. When the tab projections 96 are captured by the mating receptacles 94, the passageway sides 98 can retract, resuming their original configuration.
When a holder 55 includes inner and outer holder members, as illustrated by FIG. 5B, the sides 99 of the outer holder member 52 can be relatively inflexible as compared to the sides 98 of the passageway 86 of the inner holder member 56. Thesheath 20 can be inserted into the inner holder member 56, the sheath guide 84 passed along the passageway 86 of the inner holder member 56, and the tab projections 96 of the sheath 20 captured by the corresponding mating receptacles 94 on the inner holder member 56. The inner holder member 56 can then be inserted into the outer holdermember 52. Removal of the sheath 20 from the holder 55 is further limited because the CA 022~40~2 1998-11-10 outer holder member sides 99 restrict the sides 98 of the passageway 86 of the inner holder member 56 to expand to allow removal of the captured tab projections 96 from the corresponding mating receptacles 94.
FIG. 6 illustrates that the system can also include a positioning element 102, such as a hypodermic or cytoscopic needle, or a solid wire, which is configured to allow passage through the inner lumen 28 of the sheath 20 until a tip 104 at a distal end 106 of the positioning element 102 extends beyond the distal end of the sheath.
The inner lumen 28 of the sheath 20 can have an inside diameter of about .005 mm to about 7.0 mm and the sheath can have a length of about 2.5 cm to about 245 cm.
The positioning element 102 can have an outside diameter of about .003 mm to about 6.5 mm and a length of about 2.54 cm to about 250 cm. The delivery catheter can have an inside diameter of about .002 mm to about 6.5 mm and a length of about 2.5 cm to about 245 cm.
Like the holder, sheath, and delivery device, the positioning element 102 can becolor coded to facilitate insertion through the holder.
In sum, the present invention benefits from the recognition that a delivery device can be inserted through a protective sheath enclosed in a holder to the target site in vivo, and the sheath can be withdrawn such that the delivery device remains fixed relative to the holder and the balloon is exposed to the target site in vivo. The methods and systems of the present invention have several advantages over the prior art. Withdrawal of the sheath such that the delivery device remains fixed relative to the holder and the balloon is exposed to tissue provides for stable, simple and accurate balloon deployment at the target site in vivo. Other features of the invention, such as the stopper means and the stabilizing means disposed at the proximal and distal ends of the holder, respectively, and the sheath guide and holder passageway, also contribute to stable and less awkward or cumbersome balloon deployment. Further, deployment of a balloon h~d to the distal end of a delivery device via a protective sheath enclosed in a holder elimin~tes the need for the complicated instrumentation required when such balloons are deployed via hypodermic needles. The two-catheter design for balloon delivery provides more support for safely loading and transporting the balloon to the desired target site in the patient.
It will be understood that the above description pertains to only several embo-limPnt~ of the present invention. That is, the description is provided by way of illustration and not by way of limitation. For example, other means for withdrawing the sheath such that the catheter remains fixed relative to the holder and the balloon is exposed to tissue can be selected con~i~tent with the present invention. The invention is further characterized according to the following claims.
A DETACHABLE BALLOON AT A TARGET SITE IN VIVO
Back~round of the Invention The field of this invention concerns the delivery of inflatable, detachable balloons in medical procedures involving blood vessels, body cavities, and the like, and, in particular, in medical procedures involving the treatment of urinary incontin~ e.
Various techniques have been used for the delivery of detachable balloons. See, for example, Haber et al., U.s. Patent No. 4,832,680, issued May 23, 1989; U.S. Pat.
No. 4,802,479, issued Feb. 7, 1989; U.S. Pat. No. 4,773,393, issued Feb. 27, 1988, and U.S. Patent No. 4,686,962, issued Aug. 18, 1987. Haber et al., in particular, describe an extensible inflatable containment membrane which is implanted between the urethra and the subcutaneous corpus spongiousum of a patient to overcome urinary incontinence.
The containment membrane of Haber et al. is positioned using a hypodermic needle.
Such devices and methods require complicated devices for stabilizing the delivery of the balloon during the insertion and positioning. Such devices and methods also may require specialized instrumentation to accommodate balloon insertion and positioning with a hypodermic needle.
There exists a need for better methods and systems for accurate delivery of inflatable, detachable balloons. A simple system for stabilizing balloon delivery devices would satisfy a long felt need in the art by reducing the overall procedure time, ma~cimi7ing the efficacy of the methods and systems and, hence, reducing patientdiscomfort.
Summary of the Invention Methods and devices are disclosed for the deployment of detachable, inflatable balloons at a target site in a patient in vivo. The present invention is based on the recognition that a balloon delivery device can be inserted through a protective sheath which is slidably mounted within a holder. The sheath can be retracted and, if desired, locked, such that the delivery device remains fixed relative to the holder and the balloon is exposed to the target site in vivo.
In one aspect of the invention, a detachable, inflatable balloon is deployed to a target site in vivo according to the following steps. A holder having an inner lumen, a proximal receiving end and a distal exiting end is provided and a protective sheath passed through the holder inner lumen at the proximal receiving end until a distal end of the sheath extends to at least the distal exiting end of the holder. A positioning element is passed through an inner lumen of the sheath until a positioning element tip disposed at CA 022~40~2 1998-11-10 a distal end of the positioning element extends beyond the holder's distal exiting end and the distal end of the sheath. The positioning element tip is advanced to the target site in vivo and used to establish a pocket. The positioning element is then withdrawn from the sheath such that the sheath remains fixed relative to the holder. A ~let~h~ble inflatable balloon coupled to a distal end of a delivery device is passed through the sheath. The sheath is withdrawn into a retractor disposed at a proximal end of the delivery device such that the delivery device remains fixed relative to the holder and the balloon is exposed to the target site in vivo. The balloon is then infl~te~l, preferably with an inert biocompatible material (e.g. a polymerizable solution), and detached at the target site in vivo.
In one embodiment of the invention, the step of withdrawing the sheath into the delivery device retractor can include rotating the delivery device retractor such that a hub disposed at a proximal end of the sheath is withdrawn into the delivery device retractor. In another embodiment, the step of passing the balloon through the sheath can include passing the delivery device retractor over a hub disposed at the proximal end of the sheath until the delivery device retractor contacts a stopper means, disposed on the holder, for preventing passage of the delivery device through the holder beyond a pre-determined point.
In other embodiments, the step of providing the holder can include providing a stabilizing means, such as a flange, disposed at a distal exiting end of the holder, for stabilizing the holder against a surface exterior to the holder. The step of providing the holder can also include providing an outer holder member and an inner holder member, each having an inner lumen, a proximal receiving end and a distal exiting end; and inserting the inner holder member at least partially into the outer holder member to form the holder; and the step of advancing the positioning element tip to the target site in vivo can also include progressively releasing a projection element disposed on the inner holder member into corresponding projection releasing elements disposed on the outer holder member to provide a visual indication of the depth of insertion. The step of progressively releasing a projection element can include depressing a lever arm having a projection tab disposed on the inrer holder member below a surface of the outer holder member projection releasing element.c. This step can also include indexing the projection tab from one releasing element to another.
In still other embodiments, the step of passing the sheath through the holder can include passing a guide, disposed on the sheath, along a corresponding passageway, disposed on the holder, such that passage of the sheath through the holder is directed along a longitudinal axis relative to the holder. The step of passing the sheath through CA 022~40~2 1998-11-10 the holder can also include passing the sheath through the holder until a tab, disposed on the holder, is captured by at least one mating receptacle, disposed on the sheath, thereby inhibiting further movement of the sheath relative to the holder.
In further embo.liment~, the step of providing a holder can include providing a fitting means, disposed at a distal end of the holder, for providing an ~tt~r~lment to a viewing instrument; providing a sealing means disposed at the distal exiting end of the holder for providing a seal between the holder and a viewing instrument holder inner lumen; and/or providing a viewing instrument capable of ~ çhment to the distal exiting end of the holder, for directly vi.c~ ing the target site of a patient in vivo.
In another aspect of the invention, a system for deploying a detachable, inflatable balloon to a target site in vivo is disclosed. The system can include a holder having an inner lumen, a proximal receiving end and a distal exiting end; a protective sheath configured for insertion through the holder inner lumen at the proximal receiving end and extentling to at least the distal exiting end of the holder, including a hub disposed at a proximal end of the sheath, and a shaft portion extending outwardly from the hub along a longitudinal axis, the hub and the shaft each having an inner lumen; a delivery device for carrying a detachable, inflatable balloon at its distal end, the delivery device configured for insertion through the sheath; and a retractor disposed at a proximal end of the delivery device for withdrawing the sheath whereby the delivery device remains fixed relative to the holder and the balloon is exposed to the target site.
In other embodiment~, the delivery device retractor can include a head for withdrawing the hub of the sheath upon movement of the head. The head can be internally threaded for withdrawing the sheath hub upon rotation of the head. The holder can include a stopper means, disposed close to a proximal end of the holder, for limiting passage of the delivery device through the holder at a pre-determine-l point; a stabilizing means, such as a flange, disposed at a distal end of the holder, for stabilizing the holder against a surface exterior to the holder; a fitting means, disposed at the distal end of the holder, for providing an attachment to a viewing instrument; and/or a sealing means disposed at the distal exiting end of the holder for providing a seal between the holder and a viewing instrument. The system can further include a viewing instrument capable of ~tt~hment to the distal exiting end of the holder, for viewing the placement of the balloon.
In still other embodiments, the system can include a visual indication means, disposed on the holder, for providing a visual indication of a penekation depth of the sheath into the patient; and adjustment means disposed on the holder for adjusting the holder's length. The holder can include an outer holder member having projection CA 022~40~2 1998-11-10 WO 97t45067 PCT/US97/08979 releasing elements, an inner holder member having at least one projection element, and the inner holder member fitting at least partially into the outer holder member such that upon advancement of the inner holder member into the outer holder member, the inner holder member projection element is progressively released into the outer holdermember projection releasing elements to provide a visual indication of a penetration depth of the sheath in the patient. The inner holder member projection element can include a depressible lever arm having a projection tab, such that the arm can be depressed below a surface of the outer holder member projection releasing elements to provide for indexing of the projection tab from one releasing element to another.
In further embodiments, the system can include a guide disposed on the sheath and a passageway disposed on the holder, such that movement of the guide along the passageway during passage of the sheath through the holder directs the sheath along a longitudinal axis relative to the holder; and a tab, disposed on the holder, and at least one mating receptacle, disposed on the sheath, such that interconnection of the tab with the mating receptacle inhibits movement of the sheath relative to the holder; and/or a positioning element for passage through the sheath prior to passage of the deliver,v device through the sheath, for establishing a pocket at the target site in vivo.In still further embodiments, the positioning element can be a needle, such as ahypodermic or a cytoscopic needle or a solid wire. The lumen of the sheath can have an inside ~ met~r from about .005 mm to about 7.0 mm. The sheath can also include avisual indication means including graduation m~rking~ disposed on the distal end of the sheath, for providing a visual indication of a penetration depth of the sheath into the patient. The delivery device can include an inner catheter enclosed within an outer c~th~ter, the inner catheter having a distal end extending at least to a distal end of the outer ç~theter.
Brief Description of the D. ..~ s FIG. 1 is an exploded side view of the system including a holder, a protective sheath, and a delivery device according to the invention;
FIG. 2 is a more detailed side view of the retractor component of the delivery device of FIG. l;
FIG. 3A is an expanded side view of the holder of FIG. 1 having inner and outer holder members;
FIG. 3B is an illustration of the passage of a protective sheath through an inner and an outer holder member;
CA 022~40~2 1998-11-10 FIG. 3C shows the protective sheath fully inserted into a holder including an inner and an outer holder member;
FIG. 3D is an enlarged view of the holder illustrating a projection element including a lever arm having a depressible projection tab;
FIG. 4 is a more detailed side view of a holder illustrating a stopper mech~ni~m~tt~-'hP~ to a viewing instrument according to the invention;
FIG. SA is a view of a guide of a sheath being advanced along a passageway of a holder, FIG. SB is a view of a tab disposed along the passageway of a holder having inner and outer holder members, the tab having been captured by a mating receptacle disposed along a guide of a sheath; and FIG. 6 is a view of a positioning element of the system.
Detailed D~ ti~n The present invention pertains to methods and systems for the deployment of detachable inflatable balloons to a target site in vivo. The invention involves a delivery device which can be inserted through a protective sheath enclosed in a holder to the target site in vivo. The sheath can be withdrawn such that the delivery device remains fixed relative to the holder and the balloon is exposed to the target site in vivo.
The target site can be a site selected such that the implantation of a ~let7~h~ble balloon would be advantageous to a subject. The target site, for example, can be in close proximity to or within a duct and the purpose of the implantation of the detachable balloon is to block the duct from within or provide external pressure causing partial or complete closure of the duct. For example, the target site can be between the urethra and the subcutaneous corpus spongiousum. Alternatively, the target site can be the subureteral region of a reflux prone bladder.
The methods and systems of this invention can be used, for example, as a means for treating urinary incontin~nce. The infl~te~, detached balloon can be placed between the urethra and the subcutaneous corpus spongiousum providing a localized, controlled tissue volume increase. The corpus spongiousum would be expanded, thereby occluding the urethra.
In an additional example, the methods and systems of this invention can be used for the treatment of vesicoureteral reflux. The infl~tecl detached balloon can be placed in the subureteral region of a refluxing bladder (e.g., between the mucosal and submucosal tissue layers). The compressive effect of the infl~te~l balloon can then re-configure the ureteral tunnel so as to minimi7P the likelihood of reflux.
CA 022~40~2 1998-11-10 WO 97145067 PCTtUS97/08979 The present invention can also be used in other types of medical treatments, including, but not limited to, the tre~tment of gastroesophageal reflux, otolaryngology, reversible sterilization (i.e., in the occlusion of the fallopian tubes and/or the occlusion of the vas deferens), and urinary diverticula.
Balloon structures useful in the present invention can be formed from silicone or similar substantially non antigenic elastic materials. The lminfl~tecl balloons preferably are sized to fit into the tip of a catheter which can pass readily through the lumen of a protective sheath. The balloon structures can take various forms but preferably include a sealing mecl-~ni~m which seals the balloon upon inflation. The sealing mech~ni~m can be achieved, for example, by a constrictive collar, or a lip seal, or both.
For further description of detachable balloon structures useful in the present invention, see commonly owned U.S. PatentNos. 5,304,123 and 5,411,475, herein incorporated by reference.
The balloon can be delivered by a delivery device, such as a catheter, which is inserted through the protective sheath enclosed in a holder to the site where the balloon is to be infl~tetl In one preferred embodiment, the delivery device provides a means for not only infl~ting the balloon but also means for filling the balloon with a biocompatible material. Catheters suitable for use in the present invention are available from various sources including, for example, TFX Medical (Jaffrey, N.H.).
Various materials can be used to fill the balloon, including collagen, autologous fat or cellular extracts, an inert polymer, contrast media or saline. In one embodiment, the balloon is filled with a polymerizable solution, such as an acrylic solution which solidifies in situ. For example, the polymerizable solution can be a solution ofhydroxyethyl methylacrylate (HEMA) which is cured to a solid form by addition offerrous sulfate and hydrogen peroxide. In another embodiment, the balloon is filled with a hydrogel material such as polyvinyl pyrrolidone.
The invention will next be described in connection with certain illustrated embodiments; however, it should be clear that those skilled in the art can make various modifications, additions and subtractions without departing from the spirit or scope of the invention. For example, although the present invention is illustrated in terms of a target site close to or within a duct, the invention is applicable to other target areas in a body.
FIG. 1 is an exploded side view of system 10 including a holder 12, a protectivesheath 20, and a delivery device 30, according to the invention. The holder 12 has an inner lumen 14, a proximal receiving end 16, and a distal exiting end 18. The protective sheath 20 can be configured for insertion through the holder 12 at the proximal receiving CA 022~40~2 1998-11-10 end 16 such that it extends at least to the distal exiting end 18 of the holder 12 and can include a hub 22 disposed at the proximal end 24 of the sheath 20, and a shaft portion 26 exten/ling outwardly from the hub 22 along a longihl-lin~l axis 27, the hub 22 and the shaft portion 26 each having an inner lumen 28. The sheath 20 can also include visual indication means 78, such as graduation m~rkin~, disposed on the distal end of the shaft portion 26 of the sheath 20 for indicating the penetration depth of the sheath into the patient according to a pre-determined correlation. The delivery device 30 for carrying a detachable, inflatable balloon 32 at its distal end 34, is configured for insertion through the sheath 20 at the hub 22. A retractor 40 is disposed at a proximal end 38 of the delivery device 30 for withdrawing the sheath 20 whereby the device 30 remains fixed relative to the holder 12.
Each of the holder 12, sheath 20 and delivery device 30 can be color coded for easy assembly.
FIG. 2 is a more clet~iled side view of the retractor 40 component of the delivery device 30. The delivery device retractor 40 includes a head 42 for withdrawing the hub 22 of the sheath 20 upon movement of the head. The head 42 can be intPrn~lly threaded such that the hub 22 of the sheath 20 is withdra~vn upon rotation of the threaded head.
The head 42 can also include raised external ridges 41 to aid in gripping and/or rotating the head 42. FIG.2 also illustrates that the delivery device 30 can include an inner c~th~t~r 33 enclosed within an outer catheter 31, the distal end 34 of the inner c~tht?ter 33 e~t~n-ling at least to the distal end 35 of the outer catheter 31. Such a t~vo catheter design provides more support for safely transporting the balloon 32 to the desired target site in the patient.
FIG. 3A illustrates that the system 10 can also include a holder 55 including a visual indication means 50 for providing a visual indication of a penetration depth of the sheath 20 into the patient and an adjustment means 51 for varying the length of the holder. Such a holder 55 can include an outer holder member 52 having projectionreleasing elements 54 and an inner holder member 56 having at least one projection element 58. FIG.3B illustrates that the sheath 20 can be inserted into the lumen 62 of the inner holder member 56 and the lumen 64 of the outer holder member 52 such that the sheath 20 extends at least to the distal end 66 of the inner holder member 56 and the distal end 68 of the outer holder member 52. The inner holder member 56 enclosing the sheath 20 can fit at least partially into the outer holder member 52. As the inner holder member 56 enclosing the sheath 20 is further advanced into the outer holder member 52, the projection element 58 is progressively released into the projection releasing elements 54 providing a visual indication of a penetration depth of the sheath 20 into the patient, CA 022~40~2 1998-11-10 as shown in FIG. 3C. FIG. 3D illustrates that the projection element 58 of the inner holder member 56 can include a lever arm 70 having a projection tab 71 that can be depressed such that the projection tab 71 is indexed from one releasing element 54 to another during advancement of the inner holder member 56 into the outer holder member 52.
FIG. 4 is a more detailed side view of the holder 12 including a stopper means 72, disposed on the holder 12, for preventing further movement of the delivery device retractor 40 over the holder 12 and thus limiting passage of the delivery device 30 through the holder 12 at a pre-determined point. Stopper means 72 also provides a place for the physician to position his or her index and middle fingers, simplifying maneuvering of the system. FIG. 4 further illustrates a stabilizing means 74, such as a flange, disposed on the distal exiting end 18 of the holder 12, for stabilizing the holder 12 against a surface exterior to the holder 12. The distal exiting end 18 of the holder 12 can also include a fitting means 76 for attachment to a viewing instrument 80. The system 10 can include such a viewing instrument 80 capable of ~ hment to the distal exiting end of the holder 12. The holder 12 can further include a sealing means 82 disposed at the distal exiting end of the holder 12 for providing a seal between the holder 12 and the viewing instrument 80, thereby preventing the back-flow of fluids into the holder inner lurnen. The sealing means 82 can be made of a variety of materials, such as silicone, known to persons f~mili~r with the art.
Thus, for example, in the tre~tment of urinary incontinPn~e, the protective sheath 20 can be passed through a lumen of a viewing instrument 80 and the viewing instrument can be passed via the urethra to a target site between the urethra and the subcutaneous corpus spongiousum for injection and detachment of the balloon sul~Lllldl delivery). Alternatively, the protective sheath 20 and the viewing instrument 80 can be passed in parallel via the urethra to the target site. In addition, the protective sheath 20 can be passed through the patient's tissue parallel to the urethra to the target site for injection and detachment of the balloon 32 (pcl;u~clhldl delivery).
Positioning of the sheath can be observed via a viewing instrument passed through, for example, the urethra.
In an alternative example involving the treatment of vesicoureteral reflux, the protective sheath 20 can be passed through a lumen of a viewing instrument 80 which can be passed through the ureter to a target site (e.g., the subureteral region of a u~hlg ureter between the mucosal and submucosal tissue layers).
Various materials can be used for the sheath and/or the positioning element. Forexample, a flexible material such as nickel titanium is preferable for the sheath and/or . . .
CA 022~40~2 1998-11-10 W O 97/45067 PCTrUS97/08979 the positioning element, when these components are passed through the lumen of aviewing instrument as, for example, during transurethral delivery. When these components are passed through a patient's tissue as, for example, during periurethral delivery, an inflexible material such as stainless steel is preferable.
The viewing instrument of the present invention can be any scope capable of providing direct visualization of a target site. Examples of scopes which are inten~led to be encompassed by the present invention are endoscopes such as cystoscopes or ureteralscopes. Various cystoscopes can be used in the present invention and arecommercially available from various sources including, for example, Karl Storz Co.
(Culver, Calif.); and Olympus Corporation of (Wilmington, Mass.). Direct vi~ li7~tion is intt?n~çd to encompass visualization by the human eye or visu~li7~tion using a media which is an actual picture of what would be seen by the human eye looking through the scope, e.g. video.
FIG. SA illustrates that the system can include a guide 84 on the hub 22 of the sheath 20 which can be advanced along a corresponding passageway 86 on the holder 12, such that passage of the sheath 20 through the holder 12is directed along a longitudinal axis relative to the holder 12. Such movement of the guide 84 along the passageway 86 also prevents awkward rotation of the sheath 20 about the longitudinal axis of the holder 12..
FIG. 5A further illustrates that the system can include a tab 96 disposed on theholder 12 which can be captured by at least one mating receptacle 94 disposed on the guide 84 of the sheath 20 when the sheath 20is inserted to a pre-determined extent into the holder 12. In one embodiment, the tab 96 can include two projections disposed on opposing sides of the passageway 86. The insertion of the sheath 20 into the holder 12 including the movement of the guide 84 along the passageway 86 can expand the sides 98 of the passageway 86. When the tab projections 96 are captured by the mating receptacles 94, the passageway sides 98 can retract, resuming their original configuration.
When a holder 55 includes inner and outer holder members, as illustrated by FIG. 5B, the sides 99 of the outer holder member 52 can be relatively inflexible as compared to the sides 98 of the passageway 86 of the inner holder member 56. Thesheath 20 can be inserted into the inner holder member 56, the sheath guide 84 passed along the passageway 86 of the inner holder member 56, and the tab projections 96 of the sheath 20 captured by the corresponding mating receptacles 94 on the inner holder member 56. The inner holder member 56 can then be inserted into the outer holdermember 52. Removal of the sheath 20 from the holder 55 is further limited because the CA 022~40~2 1998-11-10 outer holder member sides 99 restrict the sides 98 of the passageway 86 of the inner holder member 56 to expand to allow removal of the captured tab projections 96 from the corresponding mating receptacles 94.
FIG. 6 illustrates that the system can also include a positioning element 102, such as a hypodermic or cytoscopic needle, or a solid wire, which is configured to allow passage through the inner lumen 28 of the sheath 20 until a tip 104 at a distal end 106 of the positioning element 102 extends beyond the distal end of the sheath.
The inner lumen 28 of the sheath 20 can have an inside diameter of about .005 mm to about 7.0 mm and the sheath can have a length of about 2.5 cm to about 245 cm.
The positioning element 102 can have an outside diameter of about .003 mm to about 6.5 mm and a length of about 2.54 cm to about 250 cm. The delivery catheter can have an inside diameter of about .002 mm to about 6.5 mm and a length of about 2.5 cm to about 245 cm.
Like the holder, sheath, and delivery device, the positioning element 102 can becolor coded to facilitate insertion through the holder.
In sum, the present invention benefits from the recognition that a delivery device can be inserted through a protective sheath enclosed in a holder to the target site in vivo, and the sheath can be withdrawn such that the delivery device remains fixed relative to the holder and the balloon is exposed to the target site in vivo. The methods and systems of the present invention have several advantages over the prior art. Withdrawal of the sheath such that the delivery device remains fixed relative to the holder and the balloon is exposed to tissue provides for stable, simple and accurate balloon deployment at the target site in vivo. Other features of the invention, such as the stopper means and the stabilizing means disposed at the proximal and distal ends of the holder, respectively, and the sheath guide and holder passageway, also contribute to stable and less awkward or cumbersome balloon deployment. Further, deployment of a balloon h~d to the distal end of a delivery device via a protective sheath enclosed in a holder elimin~tes the need for the complicated instrumentation required when such balloons are deployed via hypodermic needles. The two-catheter design for balloon delivery provides more support for safely loading and transporting the balloon to the desired target site in the patient.
It will be understood that the above description pertains to only several embo-limPnt~ of the present invention. That is, the description is provided by way of illustration and not by way of limitation. For example, other means for withdrawing the sheath such that the catheter remains fixed relative to the holder and the balloon is exposed to tissue can be selected con~i~tent with the present invention. The invention is further characterized according to the following claims.
Claims (17)
1. A system for deploying a detachable, inflatable balloon (32) to a target site in vivo comprising:
a holder (12) having an inner lumen (14), a proximal receiving end ( 16) and a distal exiting end (18);
a protective sheath (20) configured for insertion through the holder inner lumen at the proximal receiving end and extending to at least the distal exiting end of the holder (12). including a hub (22) disposed at a proximal end of the sheath, and a shaft portion (26) extending outwardly from the hub along a longitudinal axis, the hub and the shaft each having an inner lumen (28):
a delivery means (30) for carrying a detachable, inflatable balloon (32) at its distal end (34), the delivery means configured for insertion through the sheath (20):
and a retractor (10) disposed at a proximal end (38) of the catheter for withdrawing the sheath (20) whereby the delivery means (30) remains fixed relative to the holder (12) and the balloon (32) is exposed to the target site.
a holder (12) having an inner lumen (14), a proximal receiving end ( 16) and a distal exiting end (18);
a protective sheath (20) configured for insertion through the holder inner lumen at the proximal receiving end and extending to at least the distal exiting end of the holder (12). including a hub (22) disposed at a proximal end of the sheath, and a shaft portion (26) extending outwardly from the hub along a longitudinal axis, the hub and the shaft each having an inner lumen (28):
a delivery means (30) for carrying a detachable, inflatable balloon (32) at its distal end (34), the delivery means configured for insertion through the sheath (20):
and a retractor (10) disposed at a proximal end (38) of the catheter for withdrawing the sheath (20) whereby the delivery means (30) remains fixed relative to the holder (12) and the balloon (32) is exposed to the target site.
2. The system of claim 1, wherein the retractor (40) further comprises a head (42) for withdrawing the hub of the sheath upon movement of the head.
3. The system of claim 1, wherein the holder (12) further comprises means (72) disposed close to a proximal end (16) of the holder (12), for limiting passage of the delivery means (30) through the holder at a pre-determined point.
4. The system of claim 1, wherein the holder further comprises means (74) disposed at the distal exiting end (18) of the holder (12) for stabilizing the holder against a surface exterior to the holder.
5. The system of claim 1 further comprising:
means (50) disposed on the holder, for providing a visual indication of a penetration depth of the sheath (20) into the patient.
means (50) disposed on the holder, for providing a visual indication of a penetration depth of the sheath (20) into the patient.
6. The system of claim 1, wherein the holder (12) further comprises an outer holder member (52) having a plurality of projection releasing elements (54), an inner holder member (56) having at least one projection element (58), and the inner holder member fitting at least partially into the outer holder member such that upon advancement of the inner holder member into the outer holder, the inner holder projection element is progressively released into the projection releasing elements to provide a visual indication of the penetration depth of the sheath into the patient.
7. The system of claim 1, wherein the inner holder member (56) further comprises a depressible lever arm (70) having a projection tab (71), such that the arm (70) is depressed below a surface of the outer holder (52) member projection releasing elements to provide for indexing from one releasing element to another.
8. The system of claim 1, wherein the holder (12) further comprises means (76) disposed at the distal exiting end (18) of the holder for providing an attachment to a viewing instrument.
9. The system of claim 1, wherein the holder (12) further comprises means (82) disposed at the distal exiting end of the holder for providing a seal between the holder and a viewing instrument.
10. The system of claim 1 further comprising:
a viewing instrument (80) capable of attachment to the distal exiting end (18) of the holder (12), for viewing the placement of the balloon.
a viewing instrument (80) capable of attachment to the distal exiting end (18) of the holder (12), for viewing the placement of the balloon.
11. The system of claim 1 further comprising:
a guide (84) disposed on the sheath (20) and a passageway (86) disposed on the holder (12), such that movement of the guide along the passageway during passage of the sheath through the holder directs passage of the sheath along a longitudinal axis relative to the holder.
a guide (84) disposed on the sheath (20) and a passageway (86) disposed on the holder (12), such that movement of the guide along the passageway during passage of the sheath through the holder directs passage of the sheath along a longitudinal axis relative to the holder.
12. The system of claim 1 further comprising:
a tab (96) disposed on the holder (12) and at least one mating receptacle (94) disposed on the sheath, such that interconnection of the tab with the mating receptacle inhibits movement of the sheath relative to the holder.
a tab (96) disposed on the holder (12) and at least one mating receptacle (94) disposed on the sheath, such that interconnection of the tab with the mating receptacle inhibits movement of the sheath relative to the holder.
13. The system of claim 1 further comprising:
a positioning element (102) for passage through the sheath (20) prior to passage of the delivery means through the sheath, for establishing a pocket at the target site in vivo.
a positioning element (102) for passage through the sheath (20) prior to passage of the delivery means through the sheath, for establishing a pocket at the target site in vivo.
14. The system of claim 1, wherein the lumen (28) of the sheath has an inside diameter of from about .005 mm to about 7.0 mm.
15. The system of claim 1, wherein the sheath (20) further comprises means (78) disposed on the sheath, for providing a visual indication of a penetration depth of the sheath into the patient.
16. The system of claim 1, wherein the delivery means (30) further comprises an inner catheter (33) enclosed within an outer catheter (31), the inner catheter having a distal end extending at least to a distal end at the outer catheter.
17. The system of claim 13, wherein the positioning element (102) is a needle.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/654,838 | 1996-05-29 | ||
| US08/654,838 US5830228A (en) | 1996-05-29 | 1996-05-29 | Methods and systems for deployment of a detachable balloon at a target site in vivo |
| PCT/US1997/008979 WO1997045067A1 (en) | 1996-05-29 | 1997-05-28 | Methods and systems for deployment of a detachable balloon at a target site in vivo |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2254052A1 true CA2254052A1 (en) | 1997-12-04 |
Family
ID=24626445
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002254052A Abandoned CA2254052A1 (en) | 1996-05-29 | 1997-05-28 | Methods and systems for deployment of a detachable balloon at a target site in vivo |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US5830228A (en) |
| EP (1) | EP0959809A1 (en) |
| JP (1) | JP2000511090A (en) |
| KR (1) | KR20000016031A (en) |
| AU (1) | AU730940B2 (en) |
| CA (1) | CA2254052A1 (en) |
| WO (1) | WO1997045067A1 (en) |
Families Citing this family (101)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6045498A (en) * | 1997-06-12 | 2000-04-04 | Uromedica, Inc. | Method for adjustably restricting a body lumen |
| US6579224B1 (en) * | 1999-10-11 | 2003-06-17 | Uromedica, Inc. | Apparatus and method for inserting an adjustable implantable genitourinary device |
| US7364540B1 (en) | 1997-06-12 | 2008-04-29 | Uromedica, Inc. | Implantable device and method for adjustably restricting a body lumen |
| US6645138B2 (en) | 1997-09-12 | 2003-11-11 | Uromedica, Inc. | Adjustable implantable genitourinary device |
| US6419624B1 (en) | 1999-10-11 | 2002-07-16 | Uromedica, Inc. | Apparatus and method for inserting an adjustable implantable genitourinary device |
| US7044134B2 (en) | 1999-11-08 | 2006-05-16 | Ev3 Sunnyvale, Inc | Method of implanting a device in the left atrial appendage |
| US7128073B1 (en) | 1998-11-06 | 2006-10-31 | Ev3 Endovascular, Inc. | Method and device for left atrial appendage occlusion |
| US7713282B2 (en) | 1998-11-06 | 2010-05-11 | Atritech, Inc. | Detachable atrial appendage occlusion balloon |
| US6152144A (en) * | 1998-11-06 | 2000-11-28 | Appriva Medical, Inc. | Method and device for left atrial appendage occlusion |
| US6312405B1 (en) | 1999-02-02 | 2001-11-06 | American Medical Systems, Inc. | Self-sealing detachable balloon |
| US6248117B1 (en) | 1999-04-16 | 2001-06-19 | Vital Access Corp | Anastomosis apparatus for use in intraluminally directed vascular anastomosis |
| US7160311B2 (en) * | 1999-04-16 | 2007-01-09 | Integrated Vascular Interventional Technologies, L.C. (Ivit Lc) | Locking compression plate anastomosis apparatus |
| US6623494B1 (en) | 1999-04-16 | 2003-09-23 | Integrated Vascular Interventional Technologies, L.C. (Ivit, Lc) | Methods and systems for intraluminally directed vascular anastomosis |
| US6652542B2 (en) | 1999-04-16 | 2003-11-25 | Integrated Vascular Interventional Technologies, L.C. (Ivit, Lc) | External anastomosis operators and related systems for anastomosis |
| US6551334B2 (en) | 1999-04-16 | 2003-04-22 | Integrated Vascular Interventional Technologies, Lc | Externally directed anastomosis systems and externally positioned anastomosis fenestra cutting apparatus |
| US6726694B2 (en) | 1999-04-16 | 2004-04-27 | Integrated Vascular Interventional Technologies, L.C. (Ivit, Lc) | Intraluminally directed anvil apparatus and related methods and systems |
| US6743244B2 (en) | 1999-04-16 | 2004-06-01 | Integrated Vascular Interventional Technologies, L.C. | Soft anvil apparatus for cutting anastomosis fenestra |
| US7981126B2 (en) | 1999-04-16 | 2011-07-19 | Vital Access Corporation | Locking compression plate anastomosis apparatus |
| EP1189552B1 (en) | 1999-04-30 | 2009-04-01 | Uromedica Inc. | Apparatus with an adjustable sling for treatment of urinary stress incontinence |
| US6231561B1 (en) | 1999-09-20 | 2001-05-15 | Appriva Medical, Inc. | Method and apparatus for closing a body lumen |
| US6652555B1 (en) | 1999-10-27 | 2003-11-25 | Atritech, Inc. | Barrier device for covering the ostium of left atrial appendage |
| US6551303B1 (en) | 1999-10-27 | 2003-04-22 | Atritech, Inc. | Barrier device for ostium of left atrial appendage |
| US6689150B1 (en) | 1999-10-27 | 2004-02-10 | Atritech, Inc. | Filter apparatus for ostium of left atrial appendage |
| US6994092B2 (en) | 1999-11-08 | 2006-02-07 | Ev3 Sunnyvale, Inc. | Device for containing embolic material in the LAA having a plurality of tissue retention structures |
| US6595941B1 (en) | 2000-01-11 | 2003-07-22 | Integrated Vascular Interventional Technologies, L.C. | Methods for external treatment of blood |
| US7131959B2 (en) * | 2003-01-23 | 2006-11-07 | Integrated Vascular Interventional Technologies, L.C., (“IVIT LC”) | Apparatus and methods for occluding an access tube anastomosed to sidewall of an anatomical vessel |
| US6656151B1 (en) | 2000-01-11 | 2003-12-02 | Integrated Vascular Interventional Technologies, L.C. (Ivit, Lc) | Vascular access devices and systems |
| US7118546B2 (en) * | 2000-01-11 | 2006-10-10 | Integrated Vascular Interventional Technologies, L.C. | Apparatus and methods for facilitating repeated vascular access |
| US6663590B2 (en) | 2000-01-11 | 2003-12-16 | Integrated Vascular Interventional Technologies, L.C. (Ivit, Lc) | Vascular occlusal balloons and related vascular access devices and systems |
| US6964669B1 (en) | 2000-04-12 | 2005-11-15 | Ams Research Corporation | Linear delivery system for deployment of a detachable balloon at a target site in vivo |
| US10327880B2 (en) | 2000-04-14 | 2019-06-25 | Attenuex Technologies, Inc. | Attenuation device for use in an anatomical structure |
| US6976950B2 (en) * | 2000-04-14 | 2005-12-20 | Solace Therapeutics, Inc. | Implantable valved pressure attenuation device |
| US6682473B1 (en) * | 2000-04-14 | 2004-01-27 | Solace Therapeutics, Inc. | Devices and methods for attenuation of pressure waves in the body |
| US7374532B2 (en) | 2000-04-14 | 2008-05-20 | Attenuex Technologies, Inc. | High vapor pressure attenuation device |
| US7169164B2 (en) | 2000-09-21 | 2007-01-30 | Atritech, Inc. | Apparatus for implanting devices in atrial appendages |
| US7160325B2 (en) | 2001-05-15 | 2007-01-09 | Ams Research Corporation | Implantable medical balloon and valve |
| US7338514B2 (en) | 2001-06-01 | 2008-03-04 | St. Jude Medical, Cardiology Division, Inc. | Closure devices, related delivery methods and tools, and related methods of use |
| US20030004534A1 (en) * | 2001-06-01 | 2003-01-02 | George Stephanie A. | Balloon transporter |
| EP1392394A4 (en) * | 2001-06-04 | 2005-05-18 | Albert Einstein Healthcare Network | Cardiac stimulating apparatus having a blood clot filter and atrial pacer |
| US7011671B2 (en) | 2001-07-18 | 2006-03-14 | Atritech, Inc. | Cardiac implant device tether system and method |
| JP4328209B2 (en) | 2002-01-25 | 2009-09-09 | アトリテック， インコーポレイテッド | Atrial appendage blood filtration system |
| US7976564B2 (en) | 2002-05-06 | 2011-07-12 | St. Jude Medical, Cardiology Division, Inc. | PFO closure devices and related methods of use |
| US7124570B2 (en) * | 2003-01-23 | 2006-10-24 | Integrated Vascular Interventional Technologies, L.C. | Apparatus and methods for fluid occlusion of an access tube anastomosed to an anatomical vessel |
| US20040267306A1 (en) | 2003-04-11 | 2004-12-30 | Velocimed, L.L.C. | Closure devices, related delivery methods, and related methods of use |
| US8372112B2 (en) | 2003-04-11 | 2013-02-12 | St. Jude Medical, Cardiology Division, Inc. | Closure devices, related delivery methods, and related methods of use |
| US7597704B2 (en) | 2003-04-28 | 2009-10-06 | Atritech, Inc. | Left atrial appendage occlusion device with active expansion |
| US7735493B2 (en) | 2003-08-15 | 2010-06-15 | Atritech, Inc. | System and method for delivering a left atrial appendage containment device |
| US20060241339A1 (en) * | 2005-02-23 | 2006-10-26 | Cook Timothy C | Method and apparatus for an adjustable implantable continence device |
| US20100261951A1 (en) * | 2004-02-23 | 2010-10-14 | Uromedica, Inc. | Method and apparatus for an adjustable implantable continence device |
| US8048101B2 (en) | 2004-02-25 | 2011-11-01 | Femasys Inc. | Methods and devices for conduit occlusion |
| US9238127B2 (en) | 2004-02-25 | 2016-01-19 | Femasys Inc. | Methods and devices for delivering to conduit |
| US8048086B2 (en) | 2004-02-25 | 2011-11-01 | Femasys Inc. | Methods and devices for conduit occlusion |
| US8052669B2 (en) | 2004-02-25 | 2011-11-08 | Femasys Inc. | Methods and devices for delivery of compositions to conduits |
| US8801746B1 (en) | 2004-05-04 | 2014-08-12 | Covidien Lp | System and method for delivering a left atrial appendage containment device |
| US8177760B2 (en) | 2004-05-12 | 2012-05-15 | C. R. Bard, Inc. | Valved connector |
| US20060089669A1 (en) * | 2004-09-14 | 2006-04-27 | Uromedica, Inc. | Implantation tool for adjustable implantable genitourinary device |
| EP1827527B1 (en) * | 2004-12-06 | 2016-08-24 | Cook Incorporated | Inflatable occlusion devices, methods, and systems |
| WO2006074060A2 (en) * | 2004-12-30 | 2006-07-13 | Cook Incorporated | Inverting occlusion devices and systems |
| US20060189940A1 (en) * | 2005-02-24 | 2006-08-24 | Kirsch Andrew J | Implant positioning system and method |
| JP4995811B2 (en) | 2005-04-29 | 2012-08-08 | クック・バイオテック・インコーポレーテッド | Acupuncture positive displacement implants and related methods and systems |
| US7972359B2 (en) | 2005-09-16 | 2011-07-05 | Atritech, Inc. | Intracardiac cage and method of delivering same |
| EP1940316B1 (en) | 2005-09-26 | 2015-10-21 | AttenueX Technologies, Inc. | Pressure attenuation device |
| US20070135826A1 (en) | 2005-12-01 | 2007-06-14 | Steve Zaver | Method and apparatus for delivering an implant without bias to a left atrial appendage |
| WO2007147127A2 (en) * | 2006-06-15 | 2007-12-21 | Cook Incorporated | Methods, systems, and devices for the delivery of endoluminal prostheses |
| US20080051627A1 (en) * | 2006-08-28 | 2008-02-28 | Board Of Regents, The University Of Texas System | Endoscopic insertion of balloon system and method |
| WO2008124361A2 (en) * | 2007-04-06 | 2008-10-16 | Cook Biotech Incorporated | Fistula plugs having increased column strength and fistula plug delivery apparatuses and methods |
| US8535349B2 (en) * | 2007-07-02 | 2013-09-17 | Cook Biotech Incorporated | Fistula grafts having a deflectable graft body portion |
| US9113851B2 (en) | 2007-08-23 | 2015-08-25 | Cook Biotech Incorporated | Fistula plugs and apparatuses and methods for fistula plug delivery |
| US20090069843A1 (en) * | 2007-09-10 | 2009-03-12 | Agnew Charles W | Fistula plugs including a hydration resistant component |
| CN101909534B (en) | 2007-11-16 | 2013-03-27 | 新特斯有限责任公司 | Porous containment device for stabilization of vertebral compression fractures |
| US10070888B2 (en) | 2008-10-03 | 2018-09-11 | Femasys, Inc. | Methods and devices for sonographic imaging |
| US9554826B2 (en) | 2008-10-03 | 2017-01-31 | Femasys, Inc. | Contrast agent injection system for sonographic imaging |
| WO2010068467A1 (en) | 2008-11-25 | 2010-06-17 | Attenuex Technologies, Inc. | Implant with high vapor pressure medium |
| WO2012170538A2 (en) | 2011-06-06 | 2012-12-13 | Cook Medical Technologies Llc | Vascular occlusion devices and methods |
| WO2013070686A1 (en) | 2011-11-08 | 2013-05-16 | Boston Scientific Scimed, Inc. | Handle assembly for a left atrial appendage occlusion device |
| US8894563B2 (en) | 2012-08-10 | 2014-11-25 | Attenuex Technologies, Inc. | Methods and systems for performing a medical procedure |
| US9539041B2 (en) | 2013-09-12 | 2017-01-10 | DePuy Synthes Products, Inc. | Minimally invasive biomaterial injection system |
| US9730701B2 (en) | 2014-01-16 | 2017-08-15 | Boston Scientific Scimed, Inc. | Retrieval wire centering device |
| BR122019017170B1 (en) | 2015-08-18 | 2022-08-16 | B. Braun Melsungen Ag | CATHETER ASSEMBLY |
| US10667896B2 (en) | 2015-11-13 | 2020-06-02 | Cardiac Pacemakers, Inc. | Bioabsorbable left atrial appendage closure with endothelialization promoting surface |
| EP3445284B1 (en) | 2016-04-21 | 2023-05-24 | Zenflow, Inc. | Systems for implants and deployment devices |
| AU2017371223B2 (en) | 2016-12-09 | 2023-04-27 | Zenflow, Inc. | Systems, devices, and methods for the accurate deployment of an implant in the prostatic urethra |
| WO2018200891A1 (en) | 2017-04-27 | 2018-11-01 | Boston Scientific Scimed, Inc. | Occlusive medical device with fabric retention barb |
| EP3459469A1 (en) | 2017-09-23 | 2019-03-27 | Universität Zürich | Medical occluder device |
| US10952741B2 (en) | 2017-12-18 | 2021-03-23 | Boston Scientific Scimed, Inc. | Occlusive device with expandable member |
| US11413048B2 (en) | 2018-01-19 | 2022-08-16 | Boston Scientific Scimed, Inc. | Occlusive medical device with delivery system |
| EP3787484A1 (en) | 2018-05-02 | 2021-03-10 | Boston Scientific Scimed Inc. | Occlusive sealing sensor system |
| WO2019222382A1 (en) | 2018-05-15 | 2019-11-21 | Boston Scientific Scimed, Inc. | Occlusive medical device with charged polymer coating |
| EP3793476A4 (en) | 2018-05-17 | 2022-06-15 | Zenflow, Inc. | Systems, devices, and methods for the accurate deployment and imaging of an implant in the prostatic urethra |
| WO2019237004A1 (en) | 2018-06-08 | 2019-12-12 | Boston Scientific Scimed, Inc. | Medical device with occlusive member |
| US11123079B2 (en) | 2018-06-08 | 2021-09-21 | Boston Scientific Scimed, Inc. | Occlusive device with actuatable fixation members |
| US11382635B2 (en) | 2018-07-06 | 2022-07-12 | Boston Scientific Scimed, Inc. | Occlusive medical device |
| WO2020041437A1 (en) | 2018-08-21 | 2020-02-27 | Boston Scientific Scimed, Inc. | Projecting member with barb for cardiovascular devices |
| US11850377B2 (en) | 2018-12-17 | 2023-12-26 | B. Braun Melsungen Ag | Catheter assemblies and related methods |
| EP3920771A4 (en) | 2019-02-07 | 2022-11-02 | Solace Therapeutics, Inc. | Pressure attenuation device |
| US11510766B2 (en) | 2019-02-14 | 2022-11-29 | Uromedica, Inc. | Method and apparatus for monitoring implantable device for urinary continence |
| CN114126540A (en) | 2019-07-17 | 2022-03-01 | 波士顿科学医学有限公司 | Continuous covering left atrial appendage implant |
| EP3986284A1 (en) | 2019-08-30 | 2022-04-27 | Boston Scientific Scimed, Inc. | Left atrial appendage implant with sealing disk |
| EP4033999A2 (en) | 2019-09-26 | 2022-08-03 | Universität Zürich | Left atrial appendage occlusion devices |
| CN114786629A (en) | 2019-11-19 | 2022-07-22 | 真复灵公司 | Systems, devices, and methods for accurate deployment and imaging of implants in the prostatic urethra |
| WO2021195085A1 (en) | 2020-03-24 | 2021-09-30 | Boston Scientific Scimed, Inc. | Medical system for treating a left atrial appendage |
Family Cites Families (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2513014A (en) * | 1946-11-18 | 1950-06-27 | Abbott Lab | Apparatus for implanting medicinal pellets subcutaneously |
| US2856920A (en) * | 1955-05-27 | 1958-10-21 | Indelicato Vincent | Vaginal appliance |
| US3834394A (en) * | 1969-11-21 | 1974-09-10 | R Sessions | Occlusion device and method and apparatus for inserting the same |
| US3831585A (en) * | 1972-07-19 | 1974-08-27 | T Brondy | Retrograde renal biopsy device |
| US3795246A (en) * | 1973-01-26 | 1974-03-05 | Bard Inc C R | Venocclusion device |
| US4019499A (en) * | 1976-04-22 | 1977-04-26 | Heyer-Schulte Corporation | Compression implant for urinary incontinence |
| US4240433A (en) * | 1977-07-22 | 1980-12-23 | Bordow Richard A | Fluid aspiration device and technique for reducing the risk of complications |
| US4341218A (en) * | 1978-05-30 | 1982-07-27 | University Of California | Detachable balloon catheter |
| US4327734A (en) * | 1979-01-24 | 1982-05-04 | White Jr Robert I | Therapeutic method of use for miniature detachable balloon catheter |
| US4282875A (en) * | 1979-01-24 | 1981-08-11 | Serbinenko Fedor A | Occlusive device |
| US4346712A (en) * | 1979-04-06 | 1982-08-31 | Kuraray Company, Ltd. | Releasable balloon catheter |
| US4334327A (en) * | 1979-12-21 | 1982-06-15 | University Of Utah | Ureteral prosthesis |
| US4395806A (en) * | 1980-05-08 | 1983-08-02 | Sorenson Research Co., Inc. | Method of manufacturing a detachable balloon catheter assembly |
| US4311146A (en) * | 1980-05-08 | 1982-01-19 | Sorenson Research Co., Inc. | Detachable balloon catheter apparatus and method |
| US4429724A (en) * | 1980-10-20 | 1984-02-07 | Cardiovascular Diagnostic Services, Inc. | Pressure generator for intravascular dilator |
| US4364392A (en) * | 1980-12-04 | 1982-12-21 | Wisconsin Alumni Research Foundation | Detachable balloon catheter |
| US4520823A (en) * | 1981-04-03 | 1985-06-04 | Leveen Harry H | Catheter with separable balloons |
| US4545367A (en) * | 1982-07-16 | 1985-10-08 | Cordis Corporation | Detachable balloon catheter and method of use |
| US4441495A (en) * | 1982-08-16 | 1984-04-10 | Becton, Dickinson And Company | Detachable balloon catheter device and method of use |
| US4517979A (en) * | 1983-07-14 | 1985-05-21 | Cordis Corporation | Detachable balloon catheter |
| US4557255A (en) * | 1983-08-22 | 1985-12-10 | Goodman Tobias M | Ureteroscope |
| US4559043A (en) * | 1984-10-29 | 1985-12-17 | Drs Infusion Systems, Inc. | Assembly with septum fitting for connecting adaptor and fluid tube |
| GB2185400B (en) * | 1986-01-16 | 1989-10-25 | Thomas Vincent Taylor | Apparatus for arrest of bleeding at a duodenal ulcer |
| US4832680A (en) * | 1986-07-03 | 1989-05-23 | C.R. Bard, Inc. | Apparatus for hypodermically implanting a genitourinary prosthesis |
| US4686962A (en) * | 1986-07-03 | 1987-08-18 | Habley Medical Technology Corporation | Disposable cartridge assembly for hypodermically implanting a genitourinary prosthesis |
| US4773393A (en) * | 1986-07-03 | 1988-09-27 | C. R. Bard, Inc. | Hypodermically implantable genitourinary prosthesis |
| US4802479A (en) * | 1986-10-31 | 1989-02-07 | C. R. Bard, Inc. | Hand-held instrument for implanting, dispensing, and inflating an inflatable membrane |
| US5007898A (en) * | 1988-06-02 | 1991-04-16 | Advanced Surgical Intervention, Inc. | Balloon dilatation catheter |
| US4846784A (en) * | 1987-07-01 | 1989-07-11 | C. R. Bard, Inc. | Manually adjustable sphincteric system |
| US4819637A (en) * | 1987-09-01 | 1989-04-11 | Interventional Therapeutics Corporation | System for artificial vessel embolization and devices for use therewith |
| US5078681A (en) * | 1989-10-23 | 1992-01-07 | Olympus Optical Co., Ltd. | Balloon catheter apparatus with releasable distal seal and method of operation |
| US5071429A (en) * | 1990-08-24 | 1991-12-10 | Medical Engineering Corporation | Method for inserting a balloon catheter through an endoscope |
| US5222970A (en) * | 1991-09-06 | 1993-06-29 | William A. Cook Australia Pty. Ltd. | Method of and system for mounting a vascular occlusion balloon on a delivery catheter |
| US5304123A (en) * | 1991-10-24 | 1994-04-19 | Children's Medical Center Corporation | Detachable balloon catheter for endoscopic treatment of vesicoureteral reflux |
-
1996
- 1996-05-29 US US08/654,838 patent/US5830228A/en not_active Expired - Lifetime
-
1997
- 1997-05-28 EP EP97926748A patent/EP0959809A1/en not_active Withdrawn
- 1997-05-28 CA CA002254052A patent/CA2254052A1/en not_active Abandoned
- 1997-05-28 JP JP09542859A patent/JP2000511090A/en active Pending
- 1997-05-28 KR KR1019980709594A patent/KR20000016031A/en not_active Application Discontinuation
- 1997-05-28 WO PCT/US1997/008979 patent/WO1997045067A1/en not_active Application Discontinuation
- 1997-05-28 AU AU31442/97A patent/AU730940B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| AU730940B2 (en) | 2001-03-22 |
| KR20000016031A (en) | 2000-03-25 |
| WO1997045067A1 (en) | 1997-12-04 |
| JP2000511090A (en) | 2000-08-29 |
| AU3144297A (en) | 1998-01-05 |
| US5830228A (en) | 1998-11-03 |
| EP0959809A1 (en) | 1999-12-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5830228A (en) | Methods and systems for deployment of a detachable balloon at a target site in vivo | |
| US6162231A (en) | Stent insertion device | |
| US6221081B1 (en) | Insertion device for stents and methods for use | |
| EP0630658B1 (en) | Hyterosalpingography and selective salpingography | |
| US5411475A (en) | Directly visualized method for deploying a detachable balloon at a target site in vivo | |
| JP4570957B2 (en) | Medical device delivery device | |
| CA2381942C (en) | Apparatus for forming implants in gastrointestinal tract and kit for use therewith | |
| EP1314404A2 (en) | Endoscopic transduodenal biliary drainage system | |
| EP2967819B1 (en) | Devices for urethral treatment | |
| CA2283827C (en) | Balloon catheter for puncturing, medical tube introducing device using the catheter and method for use thereof | |
| US7628795B2 (en) | Tunneling device for use with a graft | |
| US20020151879A1 (en) | Multi-fiber laser device for shrinking tissue | |
| US8287602B2 (en) | Urinary stent | |
| US10758115B2 (en) | Mini-invasive device for the endourologic treatment | |
| JP2758349B2 (en) | Catheter tube and endoscope | |
| US6964669B1 (en) | Linear delivery system for deployment of a detachable balloon at a target site in vivo | |
| US11918278B2 (en) | Medical delivery systems and methods of using the same | |
| Carr-Locke | Biliary access during endoscopic retrograde cholangiopancreatography | |
| JP2022520441A (en) | Flexible trocar for advancing wound drain catheter through tissue with blunt tip and connector | |
| CN211633756U (en) | A remove system for urinary system support | |
| JP2009513286A (en) | Applicator and method of use |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| FZDE | Discontinued |